Cécile Béguin

发表

Role of kappa-opioid receptors in the effects of salvinorin A and ketamine on attention in rats

Joseph E. Rittiner, B. Cohen, B. Roth, 2010, Psychopharmacology.

Long-acting κ opioid antagonists nor-BNI, GNTI and JDTic: pharmacokinetics in mice and lipophilicity

B. Cohen, W. Carlezon, F. Carroll, 2012, BMC pharmacology.

Depressive-Like Effects of the κ-Opioid Receptor Agonist Salvinorin A on Behavior and Neurochemistry in Rats

Cécile Béguin, B. Cohen, M. Todtenkopf, 2006, Journal of Pharmacology and Experimental Therapeutics.

Duration of Action of a Broad Range of Selective κ-Opioid Receptor Antagonists Is Positively Correlated with c-Jun N-Terminal Kinase-1 Activation

B. Cohen, W. Carlezon, C. Chavkin, 2011, Molecular Pharmacology.

Kappa-opioid ligands in the study and treatment of mood disorders.

Cécile Béguin, B. Cohen, W. Carlezon, 2009, Pharmacology & therapeutics.

N-Substituted amino acid N'-benzylamides: synthesis, anticonvulsant, and metabolic activities.

J. Stables, H. Kohn, A. Letiran, 2004, Bioorganic & medicinal chemistry.

Functionalized amido ketones: new anticonvulsant agents.

D. Weaver, J. Stables, H. Kohn, 2003, Bioorganic & medicinal chemistry.

A quantitative structure-activity relationship study for α-substituted acetamido-N-benzylacetamide derivatives - A novel anticonvulsant drug class

D. Weaver, C. Béguin, J. Stables, 2005 .

N-Methylacetamide Analog of Salvinorin A: A Highly Potent and Selective κ-Opioid Receptor Agonist with Oral Efficacy

B. Cohen, B. Roth, Wei Xu, 2008, Journal of Pharmacology and Experimental Therapeutics.

Synthesis and in vitro evaluation of salvinorin A analogues: effect of configuration at C(2) and substitution at C(18).

B. Cohen, W. Xu, Jian-guo Li, 2006, Bioorganic & medicinal chemistry letters.

Synthesis and in vitro pharmacological studies of new C(2) modified salvinorin A analogues.

Bruce Cohen, Yulin Wang, B. Cohen, 2005, Bioorganic & medicinal chemistry letters.

Synthesis and in vitro pharmacological evaluation of salvinorin A analogues modified at C(2).

Cécile Béguin, Yulin Wang, B. Cohen, 2005, Bioorganic & medicinal chemistry letters.

N-methylacetamide analogue of salvinorin A: a highly potent and selective kappa opioid receptor agonist with oral efficacy

B. Cohen, B. Roth, W. Carlezon, 2007 .

N -Methylacetamide Analog of Salvinorin A: A Highly Potent and Selective (cid:1) -Opioid Receptor Agonist with Oral Efficacy □ S

B. Cohen, B. Roth, W. Carlezon, 2007 .

Medicinal Chemistry of Kappa Opioid Receptor Antagonists

B. Cohen, C. Béguin, C. Béguin, 2009 .

Standard protecting groups create potent and selective kappa opioids: salvinorin B alkoxymethyl ethers.

Katharine K. Duncan, B. Cohen, W. Xu, 2008, Bioorganic & medicinal chemistry.

Differential signaling properties at the kappa opioid receptor of 12-epi-salvinorin A and its analogues.

B. Cohen, L. Bohn, W. Carlezon, 2012, Bioorganic & medicinal chemistry letters.

8-epi-Salvinorin B: crystal structure and affinity at the κ opioid receptor

Katharine K. Duncan, B. Cohen, Wei Xu, 2007, Beilstein journal of organic chemistry.

Selective κ Opioid Antagonists nor-BNI, GNTI and JDTic Have Low Affinities for Non-Opioid Receptors and Transporters

Bryan L. Roth, Nicola A. Colabufo, F. Ivy Carroll, 2013, PloS one.